Canada· CA-DIN-02397765
EDARBYCLOR
A azilsartan medoxomil und diurektika product containing azilsartan medoxomil (azilsartan medoxomil potassium) + chlorthalidone, registered in Canada by BAUSCH HEALTH, CANADA INC.. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Azilsartan medoxomil und diurektika is registered in 3 of 19 countries.
Countries holding a registration under ATC C09DA09 (azilsartan medoxomil und diurektika), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Azilsartan medoxomil und diurektika · ATC C09DA09
3 / 19 countries
- Canada
- Netherlands
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) + CHLORTHALIDONE
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Country
- Canada (CA)
- ATC code
- C09DA09
- ATC class
- Azilsartan medoxomil und Diurektika
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
32 interactions on record for azilsartan medoxomil und diurektika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Azilsartan medoxomil und diurektika · interactions on record
32 records
32 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Azilsartan medoxomil und diurektika in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/344b93c0-4732-4b2d-be7c-a88ab90794a4 GET /v1/drugs/344b93c0-4732-4b2d-be7c-a88ab90794a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02397765",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C09DA09",
"schedule": [
"Prescription"
],
"drug_code": "88269",
"strengths": [
"40 MG",
"25 MG"
],
"ahfs_class": null,
"substances": [
"AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)",
"CHLORTHALIDONE"
],
"product_categorization": null
}See everything about azilsartan medoxomil und diurektika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.